CX3CL1 Antibodies

Kassianos, Wang, Sampangi, Afrin, Wilkinson, Healy: "Fractalkine-CX3CR1-dependent recruitment and retention of human CD1c+ myeloid dendritic cells by in vitro-activated proximal tubular epithelial cells." in: Kidney international, Vol. 87, Issue 6, pp. 1153-63, (2015) (PubMed).

Shin, You, Kang, Lee, Yoo, Park, Kang, Kim, Mohanty, Shaw, Montgomery, Hwang, Kang: "DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 195, Issue 6, pp. 2861-9, (2015) (PubMed).

Kehlen, Greither, Wach, Nolte, Kappler, Bache, Holzhausen, Lautenschläger, Göbel, Würl, Immel, Agaimy, Wullich, Taubert: "High coexpression of CCL2 and CX3CL1 is gender-specifically associated with good prognosis in soft tissue sarcoma patients." in: International journal of cancer, Vol. 135, Issue 9, pp. 2096-106, (2014) (PubMed).

Xie, Shi, Zhang, Zhang, Gong, Guo, Wang, Xu, Wang, Chen, Liu, Dong: "Abnormal activation of microglia accompanied with disrupted CX3CR1/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K." in: Journal of molecular neuroscience : MN, Vol. 51, Issue 3, pp. 919-32, (2013) (PubMed).

Schenkel, Fraser, Vezys, Masopust: "Sensing and alarm function of resident memory CD8⁺ T cells." in: Nature immunology, Vol. 14, Issue 5, pp. 509-13, (2013) (PubMed).

Kim, Rooper, Xie, Kajdacsy-Balla, Barbolina: "Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells." in: Molecular cancer research : MCR, Vol. 10, Issue 1, pp. 11-24, (2012) (PubMed).

Denoyer, Godefroy, Célérier, Frugier, Riancho, Baudouin, Rostène, Baudouin: "CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation." in: Mucosal immunology, Vol. 5, Issue 6, pp. 702-11, (2012) (PubMed).

Suzuki, Kubota, Miyazaki, Ishikawa, Ebisawa, Hirohata, Ogura, Mizusawa, Imai, Miyasaka, Nanki: "Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity." in: Arthritis research & therapy, Vol. 14, Issue 2, pp. R48, (2012) (PubMed).

Yeo, Kim, Ryu, Seo, Lee, Choi, Kim, Kang: "The roles of fractalkine/CX3CR1 system in neuronal death following pilocarpine-induced status epilepticus." in: Journal of neuroimmunology, Vol. 234, Issue 1-2, pp. 93-102, (2011) (PubMed).

Truman, Ford, Pasikowska, Pound, Wilkinson, Dumitriu, Melville, Melrose, Ogden, Nibbs, Graham, Combadiere, Gregory: "CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis." in: Blood, Vol. 112, Issue 13, pp. 5026-36, (2008) (PubMed).